CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Jazz Pharmaceuticals Fiscal Q4 2018 Earnings Report | CapyFin

Jazz Pharmaceuticals

JAZZ · NASDAQ🇮🇪

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 +13.43%Q3 2025 -2.38%Q2 2025 -6.35%Q1 2025 -8.64%Q4 2024 +3.22%Q3 2024 +6.87%Q2 2024 +1.88%Q1 2024 -1.32%Q4 2023 -10.10%Q3 2023 -12.83%Q2 2023 +2.22%Q1 2023 +1.23%Q4 2022 +2.81%Q3 2022 +5.07%Q2 2022 -1.03%Q1 2022 -1.91%Q4 2021 +11.41%Q3 2021 +2.26%Q2 2021 -10.05%Q1 2021 +3.44%Q4 2020 +7.31%Q3 2020 +3.16%Q2 2020 +9.21%Q1 2020 +4.20%Q4 2019 -10.90%Q3 2019 -1.05%Q2 2019 +0.87%Q1 2019 +5.86%Q4 2018 +9.17%Q3 2018 -13.42%Q2 2018 -0.57%Q1 2018 +6.31%Q4 2017 -1.79%Q3 2017 -2.75%Q2 2017 -8.14%Q1 2017 +0.12%Q4 2016 -0.91%Q3 2016 +4.73%Q2 2016 -6.05%Q1 2016 +0.72%Q4 2015 -2.89%Q3 2015 -4.52%Q2 2015 -3.37%Q1 2015 +0.31%Q4 2014 +3.42%Q3 2014 -1.85%Q2 2014 +3.74%Q1 2014 -5.79%Q4 2013 -5.64%Q3 2013 +3.51%Q2 2013 +3.26%Q1 2013 -7.14%Q4 2012 +3.12%Q3 2012 +0.44%Q2 2012 -4.92%Q1 2011 -2.36%Q1 2012 +2.02%Q1 2010 +3.80%Q4 2009 +3.80%Q4 2011 +3.80%Q3 2010 -0.63%Q3 2011 -0.63%Q2 2010 -9.23%Q2 2011 -9.23%Q4 2010 -9.23%

Feb 26, 2019

•

Dec 31, 2018

Jazz Pharmaceuticals Q4 2018 Earnings Report

Previous year: $436M

Previous year: $2.95

Previous year: $411M

Cash and Equivalents

Previous year: $386M

Previous year: $5.12B

Jazz Pharmaceuticals

Unlock previous datapoints

Jazz Pharmaceuticals

Unlock previous datapoints

Revenue by Segment

Xyrem Revenue

CapyFin.com

Defitelio/defibrotide Revenue

CapyFin.com

Vyxeos Revenue

CapyFin.com

Royalties & Contract Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Jazz Pharmaceuticals

Jazz Pharmaceuticals Revenue by Segment